Clinical observation on treatment of pediatric intractable nephropathy with modified Taohong Siwu decoction ( )

Kang-ye Yu; Xin-hua Huang; Wen-Li Li; Jin-ping Hu; Hei-da Li; Chuan-si Pan; Chun-yu Hu

doi:10.1007/BF02935010

Your Location：

Home >

Browse articles >

Clinical observation on treatment of pediatric intractable nephropathy with modified Taohong Siwu decoction ( )

Updated：2021-08-27

- Clinical observation on treatment of pediatric intractable nephropathy with modified Taohong Siwu decoction ( )
- Chinese Journal of Integrative Medicine Vol. 7, Issue 2, Pages: 94-98(2001)
- Affiliations：
  
  People’s Hospital of Yichun District of Jiangxi Province,Jiangxi
- Author bio：
- Funds：
- DOI：10.1007/BF02935010
  CLC：
- Published：2001，
Scan for full text
Yu, Ky., Huang, Xh., Li, WL. et al. Clinical observation on treatment of pediatric intractable nephropathy with modified Taohong Siwu decoction ()., CJIM 7, 94–98 (2001). https://doi.org/10.1007/BF02935010

Kang-ye Yu, Xin-hua Huang, Wen-Li Li, et al. Clinical observation on treatment of pediatric intractable nephropathy with modified Taohong Siwu decoction ( ). [J]. Chinese Journal of Integrative Medicine 7(2):94-98(2001)
Yu, Ky., Huang, Xh., Li, WL. et al. Clinical observation on treatment of pediatric intractable nephropathy with modified Taohong Siwu decoction ()., CJIM 7, 94–98 (2001). https://doi.org/10.1007/BF02935010 DOI：

Kang-ye Yu, Xin-hua Huang, Wen-Li Li, et al. Clinical observation on treatment of pediatric intractable nephropathy with modified Taohong Siwu decoction ( ). [J]. Chinese Journal of Integrative Medicine 7(2):94-98(2001) DOI： 10.1007/BF02935010.

摘要

Objective: To observe the clinical effect of Modified Taohong Siwu Decoction (MTSD) in treating pediatric intractable nephropathy (PIN).Methods: Ninety-five patients with PIN were divided into 2 groups at random. The 60 patients in the treated group were treated with MTSD and the 35 patients in the control group were treated with heparin. The clinical therapeutic effect and levels of thromboxane B2(TXB2) and 6-keto-prostacyclin Fla(6-keto-PGFla) before and after treatment were observed. Results: The total effective rate in the treated group was 81.7%

which was similar to that in the control group (80.0%

P > 0.05). The levels of TXB2 and TXB2/6-keto-PGFla ratio were higher in both groups of the patients as compared with those of the healthy control (P<0.01). After treatment

the two criteria were significantly improved in the two treated groups

as compared with those before treatment

the difference was significant (P<0.01)

while in comparison between the MTSD treated group and the control group

no significant difference was found (P >0. 05).Conclusion: MTSD has good effect in treating PIN

it could improve the metabolic unbalance of thromboxane and prostacyclin.

Abstract

which was similar to that in the control group (80.0%

P > 0.05). The levels of TXB2 and TXB2/6-keto-PGFla ratio were higher in both groups of the patients as compared with those of the healthy control (P<0.01). After treatment

the two criteria were significantly improved in the two treated groups

as compared with those before treatment

the difference was significant (P<0.01)

while in comparison between the MTSD treated group and the control group

no significant difference was found (P >0. 05).Conclusion: MTSD has good effect in treating PIN

it could improve the metabolic unbalance of thromboxane and prostacyclin.

关键词

modified Taohong Siwu decoctionpediatric intractable nephropathythromboxane B26-ke-to-prostacyclin Fla

Keywords

modified Taohong Siwu decoctionpediatric intractable nephropathythromboxane B26-ke-to-prostacyclin Fla

references

Li Hy, Sun Fe, Wang H, et al. Treatment of primary nephrotic syndrome with hyper-viscosity of blood by leech. Chin J Pediat 1995;33(1):28–30.

Chen Gt, Yang Ss, Fang Dy, et al. Practical Integrated Traditional Chinese and Western Medical Diagnostics and Therapeutics. Beijing: Chin Publishing House of Med Sci & Tech 1991:1117–1118.

Li H. Study on TXA2 and PGI2 levels and blood stasis syndrome and activating blood circulation to remove stasis. CJIM(Chin) 1995;15(11):701–702.

Li Hx, Zhang Jy, Xia W, et al. Effect and clinical significance of heparin therapy on platelet activation in patients of glomerular nephritis. Chin J of Nephrology 1999; 15(6): 380–381.

Wei Jx, Lu Ry, Yu Cl, et al. Progression of Application of Chinese Weil-Known Recipes. Beijing: Chin Publishing House of Med Sci & Tech 1991: 272–275.

Chen Kj, Zhang Zn, Liang Zj, et al. Studies of Blood Stasis Syndrome and Activating Blood Circulation to Remove Stasis. Shanghai: Shanghai Publishing House of Sci & Tech 1990:515–548.

Wang Y, Wang Yz, Ma Hy, et al. Practical Clinical Hemorrheology. Beijing: Xueyuan Publishing House 1994: 239–275.

Zhourx, Kongjs. Clinical observation on treatment of 34 cases of adult primary nephrotic syndrome type II by integrated Chinese and western medicine. CJIM(Chin) 1997; 17(4):236–237.

Li Yj, Ye Rg, Jiang T, et al. Study on treatment of primary nephrotic syndrome. Chin J Nephrology 1995; 11(3):133–134.

Chen Sh, Ye Rg, Li Hq. Clinical observation on treatment of nephritic nephrosis with integrated Chinese and western medicine. Chin J of Nephrology 1995; 11(6):357–358.

FULL TEXT LINK

More>

Views

381

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Effect of buyang huanwu decoction on plasma thromboxane b2, 6-keto-prostaglandin f1α, endothelin and calcitonin gene related peptide in primary nephrotic syndrome patients

Effects of Tangshenkang capsule on diabetic nephropathyon diabetic nephropathy

The research on the prevention and treatment of bronchial asthma by Chuanxiong Antiasthma Mixture

Related Author

No data

Related Institution

General Hospital of Jinan Military Region

The Affiliated Hospital of Shandong University of TCM

The First Affiliated Hospital of Xinxiang Medical College

Shanghai University of Traditional Chinese Medicine, Affiliated Longhua Hospital

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰